Home › Insulin Resistance › California › San Francisco
Insulin Resistance clinical trials in San Francisco, CA
5 studies for Insulin Resistance are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RecruitingHealthy volunteers welcome
- UCSF Medical Center at Parnassus, San Francisco
Type 1 Diabetes Extension Study
RecruitingObservational study
- UCSF School of Medicine, San Francisco
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
RecruitingPhase 2
- University of California San Francisco, San Francisco
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
RecruitingPhase 4
- University of California San Francisco, San Francisco
Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
RecruitingHealthy volunteers welcome
- San Francisco Research Institute, San Francisco
Insulin Resistance trials in other cities
- New York City, NY7 studies
- Aurora, CO7 studies
- Boston, MA6 studies
- St. Louis, MO6 studies
- Baltimore, MD4 studies
- Baton Rouge, LA4 studies
- Nashville, TN4 studies
- Washington, DC4 studies
- Mountain View, CA4 studies
- Ann Arbor, MI4 studies
- New Haven, CT4 studies
- Indianapolis, IN4 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.